Latest news with #ImpactDay
Yahoo
22-05-2025
- Business
- Yahoo
CORRECTION – Maravai LifeSciences Releases 2024 Sustainability Report
Accelerates product innovation, expands GMP manufacturing capacity, and deepens corporate-wide commitment to responsible growth Debuts enhanced greenhouse gas accounting across Scopes 1-3 and advances renewable energy initiatives Strengthens governance with appointment of independent Chairman of the Board and launches site level ethics liaison program SAN DIEGO, May 21, 2025 (GLOBE NEWSWIRE) -- This release corrects and replaces the version distributed earlier today at 16:05 ET. The original version included the incorrect title of 'Maravai LifeSciencesReleases 2024 Sustainability Report'. The corrected title is 'Maravai LifeSciences Releases 2024 Sustainability Report'. Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI), a global provider of lifescience reagents and services to researchers and biotech innovators through its portfolio companies TriLink BioTechnologies, Glen Research, Alphazyme, and Cygnus Technologies, today announced the publication of its 2024 Sustainability Report, available on the Company's Sustainability webpage ( The new report highlights progress during calendar year 2024 across Maravai's four priority areas – Product Innovation, Our People, Governance, and Sustainable Growth – and underscores the Company's commitment to sustainable value creation. 'By embedding sustainability into every facet of our operations—from employee engagement to GMP scaleup — we foster innovation, strengthen our business resilience, and create long-term value for all stakeholders,' said Trey Martin, Chief Executive Officer. 'Our 2024 achievements position Maravai to remain our customers' first choice as they advance their programs in next-generation therapeutics and diagnostics.' Key highlights from the 2024 report include: Product Innovation Launched 49 new products across portfolio brands, including CleanCap® M6 analog now available at GMP quality Completed state-of-the-art GMP facility in San Diego, increasing mRNA production capacity tenfold Established RNA Innovation Center in collaboration with Johns Hopkins University Added to our GMP manufacturing expertise and have now manufactured over 130 GMP batches for mRNA Our People Achieved 95% participation rate in our annual employee engagement survey, receiving over 2,600 comments Expanded WE (We are Empowered) Employee Resource Group to facilitate advocacy, mentorship, and outreach across the organization Implemented new career framework creating transparent progression paths for all employees Continued our Impact Day program throughout 2024, with employees contributing approximately 800 volunteer hours Governance Appointed healthcare industry veteran R. Andrew Eckert as independent Chairman of the Board Adopted formal, publicly available Human Rights Policy 100% of standing Board Committees chaired by independent members Strengthened intellectual property position with additional CleanCap® patents in China and Canada Sustainable Growth Enhanced greenhouse gas emissions data collection and expanded Scope 3 emissions reporting Leland, North Carolina facility's solar panels generated over 180,000 kWh, offsetting approximately 20% of facility's energy use San Diego EV charging stations helped save over 19,000 gallons of gasoline Advanced planning for lab plastics recycling program and single-use plastic phase-out The 2024 report was prepared in reference to the Global Reporting Initiative (GRI), Sustainability Accounting Standards Board (SASB) and Greenhouse Gas Protocol frameworks and maps selected disclosures to relevant U.N. Sustainable Development Goals (SDGs). About Maravai Maravai LifeSciences is an innovative lifesciences company that provides critical products to enable the development of breakthrough therapeutics, vaccines, cell and gene therapies and diagnostics. Through its TriLink BioTechnologies, Glen Research, Alphazyme and Cygnus Technologies brands, Maravai delivers complex nucleic acid chemistries, differentiated mRNA and enzyme solutions, and gold standard biologics safety tests to a global customer base spanning large pharmaceutical companies, emerging biotechs and leading academic institutions. Forward Looking Statements This press release contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, including statements related to future product offerings, facility capabilities, and sustainability initiatives. Forward-looking statements are neither historical facts nor assurances of future performance and are subject to risks and uncertainties that could cause actual results to differ materially. A detailed discussion of these risks is included in Maravai's most recent Annual Report on Form 10K and subsequent filings with the U.S. Securities and Exchange Commission. Maravai undertakes no obligation to update forward-looking statements except as required by law. CONTACT: Contact Information: Deb Hart Maravai LifeSciences + 1 858-988-5917 ir@
Yahoo
21-05-2025
- Business
- Yahoo
CORRECTION – Maravai LifeSciences Releases 2024 Sustainability Report
Accelerates product innovation, expands GMP manufacturing capacity, and deepens corporate-wide commitment to responsible growth Debuts enhanced greenhouse gas accounting across Scopes 1-3 and advances renewable energy initiatives Strengthens governance with appointment of independent Chairman of the Board and launches site level ethics liaison program SAN DIEGO, May 21, 2025 (GLOBE NEWSWIRE) -- This release corrects and replaces the version distributed earlier today at 16:05 ET. The original version included the incorrect title of 'Maravai LifeSciencesReleases 2024 Sustainability Report'. The corrected title is 'Maravai LifeSciences Releases 2024 Sustainability Report'. Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI), a global provider of lifescience reagents and services to researchers and biotech innovators through its portfolio companies TriLink BioTechnologies, Glen Research, Alphazyme, and Cygnus Technologies, today announced the publication of its 2024 Sustainability Report, available on the Company's Sustainability webpage ( The new report highlights progress during calendar year 2024 across Maravai's four priority areas – Product Innovation, Our People, Governance, and Sustainable Growth – and underscores the Company's commitment to sustainable value creation. 'By embedding sustainability into every facet of our operations—from employee engagement to GMP scaleup — we foster innovation, strengthen our business resilience, and create long-term value for all stakeholders,' said Trey Martin, Chief Executive Officer. 'Our 2024 achievements position Maravai to remain our customers' first choice as they advance their programs in next-generation therapeutics and diagnostics.' Key highlights from the 2024 report include: Product Innovation Launched 49 new products across portfolio brands, including CleanCap® M6 analog now available at GMP quality Completed state-of-the-art GMP facility in San Diego, increasing mRNA production capacity tenfold Established RNA Innovation Center in collaboration with Johns Hopkins University Added to our GMP manufacturing expertise and have now manufactured over 130 GMP batches for mRNA Our People Achieved 95% participation rate in our annual employee engagement survey, receiving over 2,600 comments Expanded WE (We are Empowered) Employee Resource Group to facilitate advocacy, mentorship, and outreach across the organization Implemented new career framework creating transparent progression paths for all employees Continued our Impact Day program throughout 2024, with employees contributing approximately 800 volunteer hours Governance Appointed healthcare industry veteran R. Andrew Eckert as independent Chairman of the Board Adopted formal, publicly available Human Rights Policy 100% of standing Board Committees chaired by independent members Strengthened intellectual property position with additional CleanCap® patents in China and Canada Sustainable Growth Enhanced greenhouse gas emissions data collection and expanded Scope 3 emissions reporting Leland, North Carolina facility's solar panels generated over 180,000 kWh, offsetting approximately 20% of facility's energy use San Diego EV charging stations helped save over 19,000 gallons of gasoline Advanced planning for lab plastics recycling program and single-use plastic phase-out The 2024 report was prepared in reference to the Global Reporting Initiative (GRI), Sustainability Accounting Standards Board (SASB) and Greenhouse Gas Protocol frameworks and maps selected disclosures to relevant U.N. Sustainable Development Goals (SDGs). About Maravai Maravai LifeSciences is an innovative lifesciences company that provides critical products to enable the development of breakthrough therapeutics, vaccines, cell and gene therapies and diagnostics. Through its TriLink BioTechnologies, Glen Research, Alphazyme and Cygnus Technologies brands, Maravai delivers complex nucleic acid chemistries, differentiated mRNA and enzyme solutions, and gold standard biologics safety tests to a global customer base spanning large pharmaceutical companies, emerging biotechs and leading academic institutions. Forward Looking Statements This press release contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, including statements related to future product offerings, facility capabilities, and sustainability initiatives. Forward-looking statements are neither historical facts nor assurances of future performance and are subject to risks and uncertainties that could cause actual results to differ materially. A detailed discussion of these risks is included in Maravai's most recent Annual Report on Form 10K and subsequent filings with the U.S. Securities and Exchange Commission. Maravai undertakes no obligation to update forward-looking statements except as required by law. CONTACT: Contact Information: Deb Hart Maravai LifeSciences + 1 858-988-5917 ir@ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
21-05-2025
- Business
- Yahoo
Maravai LifeSciencesReleases 2024 Sustainability Report
Accelerates product innovation, expands GMP manufacturing capacity, and deepens corporate-wide commitment to responsible growth Debuts enhanced greenhouse gas accounting across Scopes 1-3 and advances renewable energy initiatives Strengthens governance with appointment of independent Chairman of the Board and launches site level ethics liaison program SAN DIEGO, May 21, 2025 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI), a global provider of lifescience reagents and services to researchers and biotech innovators through its portfolio companies TriLink BioTechnologies, Glen Research, Alphazyme, and Cygnus Technologies, today announced the publication of its 2024 Sustainability Report, available on the Company's Sustainability webpage ( The new report highlights progress during calendar year 2024 across Maravai's four priority areas – Product Innovation, Our People, Governance, and Sustainable Growth – and underscores the Company's commitment to sustainable value creation. 'By embedding sustainability into every facet of our operations—from employee engagement to GMP scaleup — we foster innovation, strengthen our business resilience, and create long-term value for all stakeholders,' said Trey Martin, Chief Executive Officer. 'Our 2024 achievements position Maravai to remain our customers' first choice as they advance their programs in next-generation therapeutics and diagnostics.' Key highlights from the 2024 report include: Product Innovation Launched 49 new products across portfolio brands, including CleanCap® M6 analog now available at GMP quality Completed state-of-the-art GMP facility in San Diego, increasing mRNA production capacity tenfold Established RNA Innovation Center in collaboration with Johns Hopkins University Added to our GMP manufacturing expertise and have now manufactured over 130 GMP batches for mRNA Our People Achieved 95% participation rate in our annual employee engagement survey, receiving over 2,600 comments Expanded WE (We are Empowered) Employee Resource Group to facilitate advocacy, mentorship, and outreach across the organization Implemented new career framework creating transparent progression paths for all employees Continued our Impact Day program throughout 2024, with employees contributing approximately 800 volunteer hours Governance Appointed healthcare industry veteran R. Andrew Eckert as independent Chairman of the Board Adopted formal, publicly available Human Rights Policy 100% of standing Board Committees chaired by independent members Strengthened intellectual property position with additional CleanCap® patents in China and Canada Sustainable Growth Enhanced greenhouse gas emissions data collection and expanded Scope 3 emissions reporting Leland, North Carolina facility's solar panels generated over 180,000 kWh, offsetting approximately 20% of facility's energy use San Diego EV charging stations helped save over 19,000 gallons of gasoline Advanced planning for lab plastics recycling program and single-use plastic phase-out The 2024 report was prepared in reference to the Global Reporting Initiative (GRI), Sustainability Accounting Standards Board (SASB) and Greenhouse Gas Protocol frameworks and maps selected disclosures to relevant U.N. Sustainable Development Goals (SDGs). About Maravai Maravai LifeSciences is an innovative lifesciences company that provides critical products to enable the development of breakthrough therapeutics, vaccines, cell and gene therapies and diagnostics. Through its TriLink BioTechnologies, Glen Research, Alphazyme and Cygnus Technologies brands, Maravai delivers complex nucleic acid chemistries, differentiated mRNA and enzyme solutions, and gold standard biologics safety tests to a global customer base spanning large pharmaceutical companies, emerging biotechs and leading academic institutions. Forward Looking Statements This press release contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, including statements related to future product offerings, facility capabilities, and sustainability initiatives. Forward-looking statements are neither historical facts nor assurances of future performance and are subject to risks and uncertainties that could cause actual results to differ materially. A detailed discussion of these risks is included in Maravai's most recent Annual Report on Form 10K and subsequent filings with the U.S. Securities and Exchange Commission. Maravai undertakes no obligation to update forward-looking statements except as required by law. CONTACT: Contact Information: Deb Hart Maravai LifeSciences + 1 858-988-5917 ir@ in to access your portfolio
Yahoo
18-05-2025
- Climate
- Yahoo
Weather Authority Impact Day issued for Tuesday's severe storm threat
HUNTSVILLE, Ala. (WHNT) — While isolated storms will be possible Sunday and Monday across the Tennessee Valley, a more potent storm system is forecast to track through the area Tuesday into Wednesday. Ahead of a widespread threat of strong to severe storms, The Weather Authority has issued an Impact Day from Tuesday afternoon into early Wednesday morning. Storms that can develop will be capable of producing damaging winds, large hail, frequent lightning, and tornadoes. Outside of storms, winds will also be on the stronger side. Gusts between 25 to 30 mph will be possible. A potent storm system is forecast to move into the region, leading to a warm front passage. This warm front passage will allow for the increase of warm and moisture into the region. The Tennessee Valley will also be placed in an area between the cold and warm fronts known as the 'warm sector'. This sector will have all the ingredients present to support the widespread coverage of strong to severe storms. The Storm Prediction Center has the area for a 30% or greater chance of a severe storm to form within 25 miles of the area highlighted in orange. Ahead of Tuesday's widespread strong to severe storm impact, multiple disturbances tracking through the area will support the chance of isolated thunderstorms. The rain chance will not be widespread, and this period is not expected to be a complete washout. This being said, isolated strong to severe storms will be possible. If these storms can develop they will be capable of producing strong winds, heavy rain, and hail. Make sure to stick with Weather Authority for the latest on the timeline and forecast updates. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
12-05-2025
- Climate
- Yahoo
Orlando weather: Thunderstorms, showers moving over Central Florida; See live radar
The Brief Central Florida can expect another round of showers and storms on Monday. With more "wind energy", all forms of severe weather will be on the table. This includes hail and gusty winds, as well as a brief tornado or two. ORLANDO, Fla. - Monday is a FOX 35 Weather Impact Day as Central Florida braces for another round of showers and storms. Track live when storms move across your area using the FOX 35 Storm Tracker Radar below. What to expect The workweek is starting off on an unsettled note thanks to a storm system on the approach. We started the morning with widespread heavy rain, and we're going to see another round this afternoon. As this area of low pressure continues to work eastbound, widespread showers and storms will move in. The atmosphere will be more dynamic, which could help make for a few stronger storms. With more "wind energy", all forms of severe weather will be on the table. This includes hail and gusty winds, as well as a brief tornado or two. The question mark is, will we be able to destabilize the atmosphere? If we don't get much sunshine, the atmosphere will remain stable, keeping the severe weather threat minimal. It is an Impact Day so be sure to keep tabs on that FOX 35 Storm Team App. With the clouds and rain around, it is looking cooler, with highs closer to 80°. Overnight, showers and storms will start to taper off with lows dipping back into the upper 60s and lower 70s. Looking ahead Tuesday is looking much drier as a whole, but I don't think we'll be completely rain-free. An isolated storm or shower is possible as this upper-level area of low pressure is essentially overhead. Most will stay dry though. High temperatures look to rebound back into the middle and upper 80s under a mix of clouds and sunshine. Partly cloudy conditions are on the docket Tuesday night as lows fall back into the middle and upper 60s. Looking ahead This slow-moving upper-low is still spinning across the Southeast on Wednesday, but it'll be lifting away from Central Florida. This could still spark a spotty shower or two but most won't see any rain at all. Chances are slim, at only 10%. The drier trend continues late week as a ridge of high pressure builds across the Southeast. That means more warmth and more sun for Central Florida. Highs surge back up to close to 90° Thursday along with plenty of sunshine. The trend of heat and abundant sun prevails into next weekend. Highs surge back up into the lower 90s on Friday with temps topping out in the middle to potentially even upper 90s by Saturday. Brevard County Flagler County Lake County Marion County Osceola County Orange County Polk County Seminole County Sumter County Volusia County U.S./National Radar Download the FOX 35 News app for latest news, weather, and traffic alerts Download the FOX 35 Storm Team Weather app for live, interactive radar Visit for interactive radar, plus updated weather graphics, maps, and images The Source This story was written based on information shared by the FOX 35 Storm Team on May 13, 2025.
